Canadian application, no grantCanada
System and method for optimizing drug therapy for the treatment of diseases
CA 2419244 A1 · Owner: Virco Bvba · Inventors: Stoffels, Paul; Groen, Kees
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns the optimization of hiv-1 therapy using the combination of a bioanalytical method, population pharmacokinetic models and phenotypic resistance testing.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 17, 2001
GrantedNo grant recorded
Term endedSeptember 17, 2021
Patent numberCA 2419244 A1
Classification (IPC)G01N33/48 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.